Nccn Guidelines | YesPress

Browse all tags

ceo2915 saas2462 ai1738 fintech1461 founder1254 b2b1081 b2b saas905 san francisco823 co-founder817 san-francisco799 y combinator772 startup736 machine learning668 enterprise software637 stanford603 series a597 venture capital577 biotech543 cybersecurity537 ai agents481 healthtech479 new york startup474 enterprise-software448 generative ai438 digital health434 agentic ai406 silicon-valley389 d2c386 ecommerce381 silicon valley381 machine-learning373 startup founder361 california351 entrepreneur350 new york347 edtech345 venture-capital340 climate tech328 newsletter321 mit302 proptech302 robotics294 y-combinator282 san francisco startup278 enterprise ai277 series b274 developer tools266 computer vision255 oncology252 open-source248 series-a244 harvard242 supply chain242 sustainability240 iot232 enterprise229 compliance226 biotechnology224 workflow automation224 founder ceo218 telehealth217 developer-tools213 healthcare213 insurtech213 blockchain212 devops209 medical devices207 series-b206 logistics200 forbes 30 under 30196 llm193 uc berkeley189 author188 generative-ai188 clean energy187 deep tech187 web3186 a16z184 cloud184 drug discovery183 no-code183 crm179 b2c177 life sciences176 artificial intelligence175 manufacturing174 payments170 general partner169 healthcare ai169 serial entrepreneur168 seed funding164 open source163 automation161 podcast160 digital transformation159 hardware159 unicorn159 marketplace154 predictive analytics152 infrastructure151

Often tagged with

ai1 oncology1 artera1 prostate-cancer1 medical-ai1 stanford1 deep-learning1 computer-vision1 ceo1 co-founder1 biomarker1 digital-pathology1 precision-medicine1 cancer-therapy1

Tagged: nccn-guidelines

1 result

Sort

Andre Esteva

Founder · Executive · Scientist

Andre Esteva

Andre Esteva, PhD, is the co-founder and CEO of ArteraAI, a medical AI company whose test for personalizing prostate cancer therapy is included in NCCN clinical guidelines, reimbursed by Medicare, and deployed internationally. A Stanford-trained AI scientist whose Nature cover paper first demonstrated that AI could match dermatologists at diagnosing skin cancer, Esteva has co-founded four companies with a combined market cap of $2.2B. Named to TIME100 Health 2025 and Modern Healthcare's 40 Under 40 for 2025, he leads a company that raised $175M total and was named a TIME 2024 Best Invention.

ai · oncologyRead →